HOMECONTACTSITE MAPSEARCH

Shareholder Briefcase
Request Printed Materials
News and Event Alerts
Glossary
News Feeds
Search

Investors and Media Relations

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.

We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.

Infinity Pharmaceuticals (NASD: INFI) 4:12 PM ET on May 8, 2008
Last Price Change Open Day High 52-Week High
7.33
0.07 up  (0.96%) 7.26 7.33 11.42
Volume Previous Close Day Low 52-Week Low
8,900 7.26 6.95 5.00

Recent Events

May 5, 2008
Infinity Pharmaceuticals First Quarter 2008 Results

May 2, 2008
Morgan Stanley 2008 Global Healthcare Unplugged Conference

more »

Annual Report

Click here to view the 2007 Annual Report


Recent Releases

May 5, 2008
Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results

Apr 28, 2008
Infinity Announces Conference Call Discussing R&D Progress and First Quarter 2008 Results

more »

© 2001-2008 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy